Severe SARS-CoV-2 infection: does the artificial sweetener sucralose play a role?

Schiffman, Susan S; Nagle, H Troy

Schiffman, Susan S; Nagle, H Troy.

Schiffman SS; Biomedical Engineering, North Carolina State University at Raleigh, Raleigh, North Carolina, USA schiffmansusan@gmail.com.
Nagle HT; Biomedical Engineering, North Carolina State University at Raleigh, Raleigh, North Carolina, USA.

BMJ Open Gastroenterol ; 10(1)2023 05.

Article in English | MEDLINE | ID: covidwho-2319008

Subject(s)

COVID-19; Sweetening Agents; Humans; Sweetening Agents/adverse effects; SARS-CoV-2; Sucrose/adverse effects

Keywords

BIFIDOBACTERIA; COLONIC BACTERIA; COLONIC MICROFLORA; COVID-19; INTESTINAL MICROBIOLOGY

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sweetening Agents / COVID-19 Limits: Humans Language: English Year: 2023 Document Type: Article Affiliation country: Bmjgast-2023-001159

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google